Australia News
-
Ace swimmer Micheal Phelps joins Australia's Medibio board
Australia | News | 0 Comment | 09 Jun, 2017
Singapore: Ace American Swimmer and one of the most celebrated athlete in Olympic history, Mr Micheal Phelps has joined the Medibio board. Medibio is an Australian-listed medical technology...Read more
-
QIC Consortium to buy Australian Icon Group for A$1 Billion
Australia | News | 0 Comment | 23 May, 2017
A consortium comprising QIC Ltd., Goldman Sachs Group Inc.’s private equity arm and China’s Pagoda Investment agreed to buy Australian healthcare company Icon Cancer Care Group....Read more
-
Australia | News | 0 Comment | 12 May, 2017
Stroke Foundation will provide more than $205,000 to eight Australian researchers, underpinning new research projects and supporting future leaders in stroke. The Stroke Foundation is dedic...Read more
-
New imaging technique for removing tumors
Australia | News | 0 Comment | 12 May, 2017
Researchers at BRITElab at Harry Perkins Institute of Medical Research and the University of Western Australia have developed an imaging technique that assists surgeons to effectively remov...Read more
-
Ex-Telstra executive Ballantyne takes charge of Healthscope
Australia | News | 0 Comment | 27 Apr, 2017
Gordon Ballantyne, previously at Telstra, is joining the top ranks of Australia’s healthcare sector following the latest chief executive exit from the volatile industry. Mr Ballantyn...Read more
-
Australia slashes prescription drug prices
Australia | News | By BioSpectrum Bureau | 0 Comment | 31 Mar, 2017
Singapore: Bringing in much needed relief for millions of consumers, the Australian government announced that is reducing the price of 1,100 medicine brands listed on the Pharmaceutical Ben...Read more
-
Pfizer announces closure of its Australian facility
Australia | News | By BioSpectrum Bureau | 0 Comment | 16 Feb, 2017
Singapore: Global pharma giant Pfizer recently announced its plans to close an Australian manufacturing plant by 2021 that produces, an intermediate of a biosimilar to Amgen's Neulasta (peg...Read more
-
Bionomics progresses to develop novel drug for CNS
Australia | News | By BioSpectrum Bureau | 0 Comment | 10 Feb, 2017
Singapore: Bionomics, a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of diseases of the central nervous system (CNS) and c...Read more
-
Australian research receives A$125 mn funding boost
Australia | News | By BioSpectrum Bureau | 0 Comment | 09 Feb, 2017
Singapore: In a bid to further boost research and development, Australian government has announced afresh series of funding for the country's research activities. The National Health and Me...Read more
-
Medicines Australia, MTP Connect ink MoU to boost innovation
Australia | News | By BioSpectrum Bureau | 0 Comment | 31 Jan, 2017
Singapore: In a bid to boost the country's pharmaceutical sector and encourage new drug invention, The Medical Technologies, Biotechnologies and Pharmaceuticals Industry Growth Centre - and...Read more
-
Google launches health cards in Australia
Australia | News | By BioSpectrum Bureau | 0 Comment | 02 Feb, 2017
Singapore: Making a foray into healthcare, Google has recently launched health condition cards in Australia, that is touted to accurately answer the common health conditions queries. They w...Read more
-
Mainstay Medical seeks Australian approval to sell ReActiv8
Australia | News | By BioSpectrum Bureau | 0 Comment | 18 Jan, 2017
Singapore: As per reports, global medical device firm Mainstay Medical has sought approval to market i its implantable device for chronic low back pain in Australia. The Dublin company is s...Read more
-
Australia approves drug that can 'melt away' cancer cells
Australia | News | By BioSpectrum Bureau | 0 Comment | 10 Jan, 2017
Singapore: Australian authorities have just approved a new drugvenetoclax that is touted to have the power to "melt away" certain advanced forms of chronic lymphocytic leukaemia (CLL). Leuk...Read more
-
GSK to shut down its Sydney plant by 2020
Australia | News | By BioSpectrum Bureau | 0 Comment | 07 Nov, 2016
Singapore: According to reports, British drug giant GlaxoSmithKline will close its Sydney plant by 2020 after a review determined it was not competitive long term. The move will impact near...Read more
-
Australia changes drug approval norms to speed up approval process
Australia | News | By BioSpectrum Bureau | 0 Comment | 21 Sep, 2016
Singapore: With a view to speed up the approval process and improve access to breakthrough drugs, the Australian federal government is implementing new measures for approval of new medicine...Read more
-
Hypoglycaemia monitor for diabetics wins award
Australia | News | By BioSpectrum Bureau | 0 Comment | 14 Mar, 2012
AIMEDICS, an Australian medical device company, has come up with a device that help people with insulin-dependent diabetes mellitus (IDDM) by detecting and preventing sleep-time hypoglycem...Read more
-
Research and innovation critical for productivity'
Australia | News | By BioSpectrum Bureau | 0 Comment | 16 Jun, 2014
Singapore: The report, entitled 'The role of science research and technology in lifting Australian productivity,' makes 25 key findings about Australia's current performance and outlines op...Read more
-
Phosphagenics patch delivers Oxymorphone for 72 hours
Australia | News | By BioSpectrum Bureau | 0 Comment | 26 Mar, 2013
Singapore: Australian drug delivery technology company, Phosphagenics highlighted that it has achieved all end points of its important phase I trial of its oxymorphone patch by successfully...Read more
